MENU

APRE Aprea Therapeutics Forecast, Technical & Fundamental Analysis

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers... Show more

APRE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
APRE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

APRE is expected to report earnings to rise 167.86% to -18 cents per share on November 05

Aprea Therapeutics APRE Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.11
Q1'26
Missed
by $0.10
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.19
The last earnings report on August 12 showed earnings per share of -7 cents, beating the estimate of -18 cents. With 94.87K shares outstanding, the current market capitalization sits at 9.74M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3805 Old Easton Road
Phone
+1 215 948-4119
Employees
8
Web
https://www.aprea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NYXH1.540.04
+2.67%
Nyxoah SA
ZTG0.780.01
+1.17%
Zenta Group Company Limited
ALRS33.270.34
+1.03%
Alerus Financial Corp
RJF173.46-0.07
-0.04%
Raymond James Financial
SITE92.82-1.96
-2.07%
SiteOne Landscape Supply

APRE and Stocks

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-1.19%
ATOS - APRE
32%
Poorly correlated
+7.26%
WVE - APRE
28%
Poorly correlated
-1.71%
NTLA - APRE
28%
Poorly correlated
-1.59%
MBRX - APRE
27%
Poorly correlated
-13.85%
STTK - APRE
27%
Poorly correlated
+0.81%
More
Aprea Therapeutics (APRE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com